佐力药业：携手浙江大学 布局AI加码“一路向C”

Group 1 - The core viewpoint of the news is that Zhaoli Pharmaceutical has signed a cooperation agreement with Zhejiang University to establish a joint research center focused on the integration of artificial intelligence in the development of health products based on the unique properties of the Wuling fungus [1][2] - The collaboration aims to create a knowledge graph for food and medicine, develop AI-driven models and intelligent agents for functional food formulation, and assist in the long-term technological development strategy of the company [1][2] - Zhaoli Pharmaceutical's strategy "一路向C" focuses on expanding into the consumer market, leveraging market opportunities arising from external policies and the aging population, while enhancing its product offerings and brand recognition [2] Group 2 - The company anticipates a strong financial performance, projecting a net profit of 36.8 million to 38.8 million yuan for the first half of the year, representing a year-on-year growth of 24.30% to 31.06% [3] - The sales revenue for the company increased by approximately 12% compared to the previous year, driven by core products such as Wuling capsules and Lingze tablets, which continue to show strong market growth [3] - The establishment of the research center is expected to enhance the company's technological capabilities, enrich its product matrix, and cultivate new profit growth points, thereby supporting sustainable development [2][3]